Results: After 8 and 16 weeks of the treatment, the reduction of A1C frombaseline in the MC
group was greater than that of the placebo group (0.25 0.12%, P ¼ 0.042 and 0.31 0.15%,
P ¼ 0.044, respectively). In addition, the MC group showed a significant decline of total
advanced glycation endproducts (AGEs) in serum after 16 weeks of the intervention. The
mean difference between both groups was 8.22 3.58 103 AU/g protein (P ¼ 0.028). The
levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and serum
creatinine (Cr) did not change from baseline in each group and were not different between
the two groups. None of participants experienced serious adverse events.
Conclusions: It is possible that this herb is beneficial not only on glycemic control, but also
on potential systemic complications of type 2 diabetes mellitus.